Medicenna Therapeutics Corp's total assets for Q2 2025 were C$32.93M, a decrease of -13.40% from the previous quarter. TSE:MDNA total liabilities were C$12.88M for the fiscal quarter, a -14.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.